Blue Pearl Dentistry in Los Angeles, California

Info
Map & Directions
  • No Records Found

    Sorry, no records were found. Please adjust your search criteria and try again.

    Google Map Not Loaded

    Sorry, unable to load Google Maps API.

  • Blue Pearl Dentistry

  • Blue Pearl Dentistry: Dr. Robert S. Huang, DDS

  • Sinai Family Dentistry: Dr Faramarz Edalat & Dr Farshad Labib

  • Sinai Family Dentistry-Dr.Faramarz Edalat

  • Z Dental Group Dentist Los Angeles

  • Joshua A. Ghiam, D.D.S. – Los Angeles Cosmetic Dentist

  • Aurora Bay Area Prices – QUAN US TIS CHARAC W/O DX US is $365

    At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10006838, regarding QUAN US TIS CHARAC W/O DX US, which is classified under revenue code 402 and associated with CPT code 0689T, the designated fee stands at $365. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • Aurora Bay Area Prices – JAK2 GENE QUANTITATIVE is $860

    At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10006915, regarding JAK2 GENE QUANTITATIVE, which is classified under revenue code 310 and associated with CPT code 81270, the designated fee stands at $860. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.

  • |
    Managing Chronic Diseases in a Primary Care Setting

    In conclusion, effective management of chronic diseases in a primary care setting demands a multifaceted approach that integrates patient education, regular monitoring, and a collaborative healthcare team. By prioritizing personalized care plans and leveraging technology, primary care providers can significantly improve patient outcomes and quality of life. However, ongoing research and policy support are essential to address the evolving challenges in chronic disease management.